Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a prospective Randomized Phase Ⅱ Trial Comparing Preoperative Chemoradiotherapy (Paclitaxel and carboplatin) Followed by Surgery to Surgery Followed by Postoperative Chemoradiotherapy (Paclitaxel and carboplatin) for Esophageal Cancer.
Epistemonikos ID: a94ac835094a5688242d7ff23db817bc6873f3a2
First added on: May 10, 2024